{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:25:54Z","timestamp":1785839154739,"version":"3.56.0"},"reference-count":36,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Fonds de la recherche du Qu\u00e9bec - Sant\u00e9 (FRQ-S)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ultrasound Obstet Gynecol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1002\/uog.15789","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T09:19:03Z","timestamp":1445332743000},"page":"548-553","source":"Crossref","is-referenced-by-count":81,"title":["Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis"],"prefix":"10.1002","volume":"47","author":[{"given":"S.","family":"Roberge","sequence":"first","affiliation":[{"name":"Department of Social and Preventive Medicine; Universit\u00e9 Laval; Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Demers","sequence":"additional","affiliation":[{"name":"Department of Social and Preventive Medicine; Universit\u00e9 Laval; Qu\u00e9bec Canada"},{"name":"Department of Obstetrics and Gynecology; Universit\u00e9 Laval; Qu\u00e9bec Canada"},{"name":"Harris Birthright Research Centre for Fetal Medicine; King's College Hospital; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Nicolaides","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine; King's College Hospital; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bureau","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Universit\u00e9 Laval; Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[{"name":"Department of Medicine; Universit\u00e9 Laval; Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bujold","sequence":"additional","affiliation":[{"name":"Department of Social and Preventive Medicine; Universit\u00e9 Laval; Qu\u00e9bec Canada"},{"name":"Department of Obstetrics and Gynecology; Universit\u00e9 Laval; Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,3]]},"reference":[{"key":"10.1002\/uog.15789-BIB0001|uog15789-cit-0001","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/uog.15789-BIB0002|uog15789-cit-0002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1002\/uog.15789-BIB0003|uog15789-cit-0003","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1002\/uog.15789-BIB0004|uog15789-cit-0004","first-page":"551","article-title":"Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis","volume":"29","author":"Roberge","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1002\/uog.15789-BIB0005|uog15789-cit-0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1002\/uog.15789-BIB0006|uog15789-cit-0006","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1160\/TH14-10-0848","article-title":"The physiologic anticoagulant and anti-inflammatory role of heparins and their utility in the prevention of pregnancy complications","volume":"113","author":"Mastrolia","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1002\/uog.15789-BIB0007|uog15789-cit-0007","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006780.pub3","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"7","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/uog.15789-BIB0008|uog15789-cit-0008","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): A multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"The Lancet"},{"key":"10.1002\/uog.15789-BIB0009|uog15789-cit-0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/uog.15789-BIB0010|uog15789-cit-0010","volume-title":"The Cochrane Collaboration","year":"2011"},{"key":"10.1002\/uog.15789-BIB0011|uog15789-cit-0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1002\/uog.15789-BIB0012|uog15789-cit-0012","volume-title":"Diagnosis and Management of Preeclampsia and Eclampsia","author":"National Instititutes of Health","year":"2000"},{"key":"10.1002\/uog.15789-BIB0013|uog15789-cit-0013","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"Magee","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1002\/uog.15789-BIB0014|uog15789-cit-0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/uog.15789-BIB0015|uog15789-cit-0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"10.1002\/uog.15789-BIB0016|uog15789-cit-0016","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/uog.15789-BIB0017|uog15789-cit-0017","unstructured":"Ferrier C Koferl U Durig P Schneider H Hypertens Pregnancy http:\/\/www.mrw.interscience.wiley.com\/cochrane\/clcentral\/articles\/939\/CN-00323939\/frame.html"},{"key":"10.1002\/uog.15789-BIB0018|uog15789-cit-0018","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1002\/uog.15789-BIB0019|uog15789-cit-0019","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"Vries","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1002\/uog.15789-BIB0020|uog15789-cit-0020","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT (vol 10, pg 64, 2012). Erratum in","volume":"13","author":"Vries","year":"Feb 2015","journal-title":"J Thromb Haemost"},{"key":"10.1002\/uog.15789-BIB0021|uog15789-cit-0021","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1002\/uog.15789-BIB0022|uog15789-cit-0022","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1160\/TH11-05-0340","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial","volume":"106","author":"Gris","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1002\/uog.15789-BIB0023|uog15789-cit-0023","first-page":"1213","article-title":"Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome","volume":"74","author":"Malinowski","year":"2003","journal-title":"Ginekol Pol"},{"key":"10.1002\/uog.15789-BIB0024|uog15789-cit-0024","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200209000-00004","article-title":"Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1002\/uog.15789-BIB0025|uog15789-cit-0025","first-page":"CR132","article-title":"The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies","volume":"12","author":"Goel","year":"2006","journal-title":"Med Sci Monitor"},{"key":"10.1002\/uog.15789-BIB0026|uog15789-cit-0026","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"HAPPY Study Group. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial","volume":"119","author":"Martinelli","year":"2012","journal-title":"Blood"},{"key":"10.1002\/uog.15789-BIB0027|uog15789-cit-0027","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1002\/uog.15789-BIB0028|uog15789-cit-0028","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","article-title":"Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women","volume":"45","author":"Mello","year":"2005","journal-title":"Hypertension"},{"key":"10.1002\/uog.15789-BIB0029|uog15789-cit-0029","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/M14-2062","article-title":"Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme","volume":"162","author":"Schleussner","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1002\/uog.15789-BIB0030|uog15789-cit-0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1002\/uog.15789-BIB0031|uog15789-cit-0031","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1002\/uog.15789-BIB0032|uog15789-cit-0032","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejogrb.2011.02.026","article-title":"Is testing for aspirin response worthwhile in high-risk pregnancy?","volume":"157","author":"Rey","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1002\/uog.15789-BIB0033|uog15789-cit-0033","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1002\/uog.15789-BIB0034|uog15789-cit-0034","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/uog.15789-BIB0035|uog15789-cit-0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0033-1338172","article-title":"Prediction of recurrent preeclampsia using first-trimester uterine artery Doppler","volume":"31","author":"Demers","year":"2014","journal-title":"Am J Perinatol"},{"key":"10.1002\/uog.15789-BIB0036|uog15789-cit-0036","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"}],"container-title":["Ultrasound in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fuog.15789","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/uog.15789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T22:54:49Z","timestamp":1625352889000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/uog.15789"}},"subtitle":["Prevention of pre-eclampsia"],"short-title":[],"issued":{"date-parts":[[2016,4,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1002\/uog.15789","archive":["Portico"],"relation":{},"ISSN":["0960-7692"],"issn-type":[{"value":"0960-7692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,3]]}}}